Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo
Pharmacology for Nurses

7.1 Introduction to Bacterial, Viral/COVID-19, and Fungal Infections

Pharmacology for Nurses7.1 Introduction to Bacterial, Viral/COVID-19, and Fungal Infections

Learning Outcomes

By the end of this section, you should be able to:

  • 7.1.1 Describe the pathophysiology of infection and the body’s defense system.
  • 7.1.2 Identify clinical manifestations related to infection.
  • 7.1.3 Identify the etiology and diagnostic studies related to infection.

Infection and the Body’s Defense System

The body’s immune system has several different means of preventing infection from various microorganisms. These different barriers to infection can be broken down into two distinct types: innate immunity and adaptive immunity.

Innate immunity is the body’s first line of defense against many types of organisms. It includes physical barriers such as the skin, the acidic pH of the stomach, phagocytic cells (e.g., macrophages), and the inflammatory cascade (see Introduction to the Immune System and the Inflammatory Response). This type of immunity does not require prior exposure to an organism to provide protection and is not specific to any type of microorganism. Innate forms of immunity work quickly, within minutes to hours.

By comparison, adaptive immunity, also known as acquired immunity, is highly specific to individual microorganisms. Adaptive immunity works through various immune cells with the ability to recognize specific targets (antigens) as belonging to the self or as foreign. When the body detects foreign antigens, the adaptive immune system can mount a response against the pathogen to eliminate it (Figure 7.2). Adaptive immunity is initially slow upon the first exposure to an antigen, but it has a “memory” that allows it to mount fast responses upon repeated exposure to that same pathogen. This immune memory is durable and able to last the individual’s whole life in some cases. This same process is how some vaccines work to induce immunity to organisms.

A diagram shows how a microphage digests a foreign bacterium. First, the bacterium engulfed by the macrophage is encased in a vacuole. Next, lysosomes fuse with the vacuole and digest the bacteria. Finally, antigens from the digested bacterium are presented with M H C 2 on the cell surface.
Figure 7.2 As part of the adaptive immune system, a macrophage engulfs and digests a foreign bacterium. (credit: modification of work from Biology for AP® Courses. attribution: Copyright Rice University, OpenStax, under CC BY 4.0 license)

When microorganisms evade the innate and adaptive immunities, infection can occur. The individual may develop signs and symptoms consistent with elevated levels of inflammation that are caused by the immune system attempting to fight the infection. These signs and symptoms can include fever, malaise, nausea, vomiting, and pain.

Various diagnostic tests are available to aid in diagnosis of an infection. These include laboratory blood tests (e.g., a complete blood count can reveal white blood cell abnormalities), imaging (e.g., a chest x-ray can reveal pneumonia), and various direct and indirect organism tests (e.g., an influenza swab can reveal the presence of influenza viral antigens). The health care provider’s choice of tests to order depends on the client.

People who are immunocompromised are more susceptible to, and have less immune defense against, infection. They may also be unable to mount “typical” signs and symptoms of infection, including fever, which can delay recognition of the infection. This can increase morbidity and mortality significantly in this client population because they are more prone to serious infections than clients with competent immune systems are. A client can be immunocompromised for a variety of reasons, such as by having human immunodeficiency virus (HIV) and the associated acquired immunodeficiency syndrome (AIDS), receiving chemotherapy for cancer treatment, or using corticosteroids (e.g., prednisone, dexamethasone). Nurses should take particular care to investigate any potential infections in clients who are immunocompromised.

Anti-infective Drugs

A variety of anti-infective medications are available today. Because many drugs are specific to the organisms that they treat, the first step in selection is to determine the most likely organism causing the infection. This allows for more judicious use of anti-infective medications and avoids the unnecessary use of drugs to treat organisms that are not present in the client. This consideration is commonly referred to as anti-infective stewardship.

Anti-infective drugs are grouped based on the organisms that they treat and include antibiotics, antivirals, antifungals, and antiparasitics. The following sections will detail the common types of anti-infectives, including their mechanisms of action, indications, adverse effects, and contraindications.

Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.